Monday, May 28, 2018

Top 10 Warren Buffett Stocks To Invest In Right Now

tags:ATU,BOFI,XENE,BRKL,HPQ,STN,RXII,LIVE,SBGL,AGEN,

When Warren Buffett announced in 2006 that he would gradually�give away the majority of his fortune to charity,�he wasn��t kidding.

The billionaire investor just donated another 18.6 million Class B shares of Berkshire Hathaway worth $3.17 billion to five different foundations. That puts his total charitable contribution to the organizations at $27.54 billion in just over ten years.

The five foundations receiving this donation include the�Bill & Melinda Gates Foundation, Susan Thompson Buffett Foundation, Sherwood Foundation, Howard G. Buffett Foundation and NoVo Foundation.

The CEO of Berkshire Hathaway is worth more than $70 billion and is ranked as the world��s second richest person, just behind Bill Gates, according to Forbes magazine. �

Buffett has made a pledge to make annual gifts of stock to the foundations throughout his lifetime and beyond.

Top 10 Warren Buffett Stocks To Invest In Right Now: Actuant Corporation(ATU)

Advisors' Opinion:
  • [By Ethan Ryder]

    Eaton (NYSE: ETN) and Actuant (NYSE:ATU) are both industrial products companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, dividends, earnings, risk, analyst recommendations, valuation and profitability.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Actuant (ATU)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Warren Buffett Stocks To Invest In Right Now: BofI Holding Inc.(BOFI)

Advisors' Opinion:
  • [By Jordan Wathen, Dan Caplinger, and Sean Williams]

    Below, three Fool.com investors make the case for adding shares of Fifth Third Bancorp (NASDAQ:FITB), BofI Holding�(NASDAQ:BOFI), and Deutsche Bank (NYSE:DB) to your portfolio.

  • [By Jason Hall]

    BofI Holding Inc�(NASDAQ:BOFI) has made for a remarkable investment over the past decade. Its stock price is up an incredible 2,140% since the start of 2008, a remarkable�17-fold�better total return than the�S&P 500�over the same period of time. Over that period it has grown its assets almost 860% and increased earnings per share almost 2,600%.�

  • [By Jason Hall]

    Internet-only bank�BofI Holding, Inc.�(NASDAQ:BOFI) reported its third-quarter fiscal 2018 earnings after market close on April 26, delivering a solid 27% increase in earnings per share. Book value per share increased 16.5% in the quarter, spurred higher by 15% growth of its loan portfolio. Deposits also grew an impressive total, up 17% in the quarter, providing BofI with the necessary cash to fund its loan growth.�

  • [By Dan Caplinger]

    The relationship between people and banks has changed dramatically over the past 20 years. Previous generations had strong personal relationships with bankers at physical branch locations in their areas, and over time, Bank of America (NYSE:BAC) has gobbled up countless smaller institutions to become the national behemoth it is today. Younger customers have gravitated toward internet banking, and BofI Holding (NASDAQ:BOFI) and its Bank of Internet USA have captured a good deal of the resulting business from those who value better rates above in-person customer service.

Top 10 Warren Buffett Stocks To Invest In Right Now: Xenon Pharmaceuticals Inc.(XENE)

Advisors' Opinion:
  • [By Lisa Levin] Gainers Red Violet, Inc. (NASDAQ: RDVT) rose 75.31 percent to close at $9.94 after reporting Q1 results. Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares jumped 40.62 percent to close at $4.50 on Tuesday after reporting 2017 year-end results. MEI Pharma, Inc. (NASDAQ: MEIP) gained 34.39 percent to close at $3.40. MEDIGUS Ltd/S ADR (NASDAQ: MDGS) gained 32.74 percent to close at $1.50 in reaction to its Monday announcement of a distribution agreement. The medical device company said it reached an agreement to distribute its minimally invasive medical devices in Turkey, Azerbaijan and Georgia. Pfenex Inc. (NYSE: PFNX) surged 31.15 percent to close at $8.00 after the company announced the positive top-line PF708 study results in Osteoporosis patients that showed no imbalances in severity or incidence of adverse events. Arcadia Biosciences, Inc. (NASDAQ: RKDA) rose 21.07 percent to close at $11.09. Arcadia Biosciences reported that Albert D. Bolles, Ph.D. has joined its board of directors. Genprex, Inc. (NASDAQ: GNPX) rose 20.23 percent to close at $10.58. Turtle Beach Corporation (NASDAQ: HEAR) shares gained 17.62 percent to close at $17.82. Aptevo Therapeutics Inc. (NASDAQ: APVO) rose 17.1 percent to close at $5.82. Phoenix New Media Limited (NYSE: FENG) shares jumped 16.23 percent to close at $4.87 following Q1 earnings. Stein Mart, Inc. (NASDAQ: SMRT) rose 16.04 percent to close at $3.69. PPDAI Group Inc. (NASDAQ: PPDF) climbed 15.99 percent to close at $7.98 following Q1 results. Tyme Technologies, Inc. (NASDAQ: TYME) rose 15.93 percent to close at $3.42. LiqTech International, Inc. (NASDAQ: LIQT) gained 15.59 percent to close at $0.5532 following Q1 results. Sophiris Bio, Inc. (NASDAQ: SPHS) gained 13.92 percent to close at $3.52 on Tuesday following Q1 results. Euroseas Ltd. (NASDAQ: ESEA) jumped 13.4 percent to close at $2.37. Iteris, Inc. (NASDAQ: ITI) shares surged 13.05 percent to close
  • [By Lisa Levin] Gainers Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares climbed 70.3 percent to $5.45 after reporting 2017 year-end results. MEDIGUS Ltd/S ADR (NASDAQ: MDGS) surged 39.8 percent to $1.58 in reaction to its Monday announcement of a distribution agreement. The medical device company said it reached an agreement to distribute its minimally invasive medical devices in Turkey, Azerbaijan and Georgia. Arcadia Biosciences, Inc. (NASDAQ: RKDA) gained 25.6 percent to $11.50. Arcadia Biosciences reported that Albert D. Bolles, Ph.D. has joined its board of directors. Aytu Bioscience Inc (NASDAQ: AYTU) shares jumped 21.8 percent to $0.4798 after the company late Monday reported lighter-than-expected Q1 loss. Hollysys Automation Technologies Ltd. (NASDAQ: HOLI) shares gained 21.1 percent to $26.77 following Q3 results. Pfenex Inc. (NYSE: PFNX) rose 16.8 percent to $7.1271 after the company announced the positive top-line PF708 study results in Osteoporosis patients that showed no imbalances in severity or incidence of adverse events. MEI Pharma, Inc. (NASDAQ: MEIP) rose 13.8 percent to $2.88. Red Violet, Inc. (NASDAQ: RDVT) jumped 13.1 percent to $6.41 after reporting Q1 results. SORL Auto Parts, Inc. (NASDAQ: SORL) shares gained 12 percent to $5.87 after reporting upbeat Q1 results. Bovie Medical Corporation (NYSE: BVX) gained 8.4 percent to $3.96 after reporting a first-quarter sales beat. Rosehill Resources Inc. (NASDAQ: ROSE) surged 8.4 percent to $7.90 after announcing Q1 results. LiqTech International, Inc. (NASDAQ: LIQT) rose 8.1 percent to $0.5171 following Q1 results. ProPhase Labs, Inc. (NASDAQ: PRPH) rose 7.7 percent to $5.6103 following Q1 results. Nine Energy Service, Inc. (NYSE: NINE) shares climbed 7.4 percent to $35.90. Xenon Pharmaceuticals Inc. (NASDAQ: XENE) rose 6.7 percent to $6.40 after the company presented XEN901 Phase 1 clinical update and XEN1101 TMS pharmacodynamic Phase 1 data. MYnd
  • [By Lisa Levin] Gainers Boot Barn Holdings, Inc. (NYSE: BOOT) rose 15.6 percent to $25.40 in pre-market trading after the company reported upbeat results for its fourth quarter and issued strong first-quarter earnings guidance. Abaxis, Inc. (NASDAQ: ABAX) rose 15.3 percent to $82.75 in pre-market trading. Zoetis Inc. (NYSE: ZTS) announced plans to acquire Abaxis for $83 per share in cash. Calumet Specialty Products Partners, L.P. (NASDAQ: CLMT) rose 12.6 percent to $8.95 in pre-market trading after reporting Q1 results. Micro Focus International plc (NYSE: MFGP) shares rose 8.8 percent to $18.59 in the pre-market trading session after the company issued strong revenue forecast for the first fiscal half of 2018. HC2 Holdings, Inc. (NASDAQ: HCHC) rose 5.6 percent to $6.60 in pre-market trading. Eleven Biotherapeutics, Inc. (NASDAQ: EBIO) shares rose 5.3 percent to $2.79 in pre-market trading. Eleven Biotherapeutics posted a Q1 loss of $0.11 per share. Imprimis Pharmaceuticals Inc (NASDAQ: IMMY) rose 5.2 percent to $2.52 in pre-market trading after reporting a first-quarter sales beat. Red Violet, Inc. (NASDAQ: RDVT) rose 4.1 percent to $10.35 in pre-market trading after climbing 75.31 percent on Tuesday. Xenon Pharmaceuticals Inc (NASDAQ: XENE) rose 3.8 percent to $6.90 in pre-market trading. The stock rose over 10 percent Tuesday after reporting its Phase 1 clinical update on XEN901 demonstrated a favorable PK profile. Sea Limited (NYSE: SE) rose 3.5 percent to $11.01 in pre-market trading after reporting Q1 results. Teva Pharmaceutical Industries Limited (NYSE: TEVA) shares rose 3.4 percent to $20.98 in pre-market trading after Buffett's Berkshire more than doubled its stake in Teva. China Internet Nationwide Financial Services Inc. (NASDAQ: CIFS) shares rose 3.7 percent to $31.30 in pre-market trading after the company reported results for its fourth quarter. PetIQ Inc (NASDAQ: PETQ) shares rose 3.4 percent to $20.00 in pre-market t
  • [By Lisa Levin] Gainers Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares rose 14.1 percent to $3.65 in the pre-market trading session after reporting 2017 year-end results. LightPath Technologies, Inc. (NASDAQ: LPTH) rose 13.3 percent to $2.43 in pre-market trading after reporting a third-quarter earnings beat. MYnd Analytics, Inc. (NASDAQ: MYND) rose 10.5 percent to $3.49 in pre-market trading. MYnd Analytics reported a Q2 net loss of $2.7 million on revenue of $459,900. SORL Auto Parts, Inc. (NASDAQ: SORL) shares rose 8.4 percent to $5.68 in pre-market trading after reporting upbeat Q1 results. Famous Dave's of America, Inc. (NASDAQ: DAVE) shares rose 7.7 percent to $8.40 in pre-market trading after the company reported upbeat earnings for its first quarter on Monday. Xenon Pharmaceuticals Inc. (NASDAQ: XENE) rose 7.5 percent to $6.45 in pre-market trading after the company presented XEN901 Phase 1 clinical update and XEN1101 TMS pharmacodynamic Phase 1 data. Mimecast Ltd (NASDAQ: MIME) rose 6.5 percent to $43.50 in pre-market trading following a first-quarter sales beat. Boxlight Corporation (NASDAQ: BOXL) rose 6 percent to $12.50 in pre-market trading after surging 77.44 percent on Monday. Intellia Therapeutics, Inc. (NASDAQ: NTLA) shares rose 6 percent to $26.05 in pre-market trading after climbing 3.58 percent on Monday. PPDAI Group Inc. (NASDAQ: PPDF) rose 4.7 percent to $7.20 in pre-market trading following Q1 results. Xunlei Limited (NASDAQ: XNET) rose 4.1 percent to $13.88 in pre-market trading after gaining 2.54 percent on Monday. Valeant Pharmaceuticals International, Inc. (NYSE: VRX) shares rose 4.5 percent to $21.73 in pre-market trading. Mizuho upgraded Valeant from Neutral to Buy. Bovie Medical Corporation (NYSE: BVX) rose 4.1 percent to $3.80 in pre-market trading after reporting a first-quarter sales beat. Myomo, Inc. (NYSE: MYO) rose 3.4 percent to $4.00 in pre-market trading after jumping 23.25 percent o
  • [By Chris Lange]

    Xenon Pharmaceuticals Inc. (NASDAQ: XENE) shares saw a handy gain on Tuesday after the firm announced positive data from a couple of its trials. Specifically, Xenon presented data from its XEN901 Phase 1 clinical trial and from its XEN1101 Phase 1 clinical trial at the Eilat Conference on New Antiepileptic Drugs and Devices in Madrid, Spain.

Top 10 Warren Buffett Stocks To Invest In Right Now: Brookline Bancorp Inc.(BRKL)

Advisors' Opinion:
  • [By Stephan Byrd]

    Brookline Bancorp, Inc. (NASDAQ:BRKL) – Equities research analysts at Piper Jaffray upped their Q3 2018 EPS estimates for shares of Brookline Bancorp in a research report issued on Thursday, May 3rd. Piper Jaffray analyst M. Breese now anticipates that the bank will post earnings of $0.28 per share for the quarter, up from their prior estimate of $0.27. Piper Jaffray has a “Hold” rating and a $16.50 price objective on the stock. Piper Jaffray also issued estimates for Brookline Bancorp’s Q4 2018 earnings at $0.29 EPS, FY2018 earnings at $1.08 EPS, Q1 2019 earnings at $0.29 EPS, Q3 2019 earnings at $0.30 EPS and FY2019 earnings at $1.18 EPS.

  • [By Joseph Griffin]

    Brookline Bancorp (NASDAQ: BRKL) and People's United Financial (NASDAQ:PBCT) are both finance companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, valuation, earnings, profitability, risk, analyst recommendations and dividends.

Top 10 Warren Buffett Stocks To Invest In Right Now: HP Inc.(HPQ)

Advisors' Opinion:
  • [By Chris Lange]

    HP Inc. (NYSE: HPQ) and Hewlett Packard Enterprise Co. (NYSE: HPE) reported their most recent quarterly results after the markets closed on Thursday. Each report was fairly positive, and these split companies both appear to be on the right track.

  • [By Paul Ausick]

    Fourth-quarter 2017 shipments of personal computers (PCs), including desktops and laptops, fell 2% year over year to an estimated 71.56 million units. HP Inc. (NYSE: HPQ) was the volume and market-share leader with worldwide shipments totaling 16.08 million in the quarter and a share of 22.5%. For the full year, worldwide shipments dipped 2.8% to 262.54 million units.

  • [By Chris Lange]

    HP Inc. (NYSE: HPQ) is set to report its most recent quarterly results on Tuesday. Analysts are looking for $0.48 in earnings per share (EPS) and $13.57 billion in revenue. Shares closed the week at $21.91, with a consensus price target of $25.76 and a 52-week trading range of $17.10 to $24.75.

  • [By ]

    Also, the installation of Visentin hints that Icahn's ultimate goal may be to drive the document processing company to sell itself to HP Inc. (HPQ) for a premium rather than merge with Fujifilm. TheStreet's sister publication, The Deal, had learned last month that HP was a possible bidder for Xerox before the Fuji deal had been struck. Another alternative is for Fujifilm to increase its offer to Xerox shareholders, though it is unclear whether a higher bid would be enough to appease Icahn.

  • [By Tyler Crowe, Leo Sun, and Brian Feroldi]

    So, we asked three of our investing contributors to highlight stocks that would be well suited for a baby boomer's portfolio. Here's a brief rundown as to why they picked HP (NYSE:HPQ), ResMed (NYSE:RMD), and American Tower (NYSE:AMT).�

Top 10 Warren Buffett Stocks To Invest In Right Now: Stantec Inc(STN)

Advisors' Opinion:
  • [By Lisa Levin] Companies Reporting Before The Bell Nomad Foods Limited (NYSE: NOMD) is estimated to report quarterly earnings at $0.36 per share on revenue of $656.43 million. AMC Networks Inc. (NASDAQ: AMCX) is expected to report quarterly earnings at $2.2 per share on revenue of $720.14 million. Magna International Inc. (NYSE: MGA) is projected to report quarterly earnings at $1.7 per share on revenue of $10.11 billion. Univar Inc. (NYSE: UNVR) is estimated to report quarterly earnings at $0.36 per share on revenue of $2.12 billion. Duke Energy Corporation (NYSE: DUK) is expected to report quarterly earnings at $1.14 per share on revenue of $5.78 billion. Owens & Minor, Inc. (NYSE: OMI) is projected to report quarterly earnings at $0.47 per share on revenue of $2.40 billion. Prestige Brands Holdings, Inc. (NYSE: PBH) is expected to report quarterly earnings at $0.61 per share on revenue of $255.60 million. Tribune Media Company (NYSE: TRCO) is projected to report quarterly earnings at $0.06 per share on revenue of $457.67 million. ArcBest Corporation (NASDAQ: ARCB) is estimated to report quarterly loss at $0.07 per share on revenue of $691.18 million. Genesis Healthcare, Inc. (NYSE: GEN) is projected to report quarterly loss at $0.34 per share on revenue of $1.32 billion. Enbridge Inc. (NYSE: ENB) is expected to report quarterly earnings at $0.55 per share on revenue of $10.14 billion. Kelly Services, Inc. (NASDAQ: KELYA) is estimated to report quarterly earnings at $0.42 per share on revenue of $1.34 billion. NICE Ltd. (NASDAQ: NICE) is expected to report quarterly earnings at $1.01 per share on revenue of $332.93 million. World Acceptance Corporation (NASDAQ: WRLD) is estimated to report quarterly earnings at $3.94 per share on revenue of $147.32 million. MAXIMUS, Inc. (NYSE: MMS) is expected to report quarterly earnings at $0.84 per share on revenue of $616.04 million. Choice Hotels International, Inc. (NYSE: CH
  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Stantec (STN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Stantec (TSE:STN) (NYSE:STN) has received a consensus rating of “Buy” from the nine research firms that are presently covering the stock, Marketbeat reports. Three investment analysts have rated the stock with a hold rating and three have given a buy rating to the company. The average twelve-month price target among brokerages that have issued a report on the stock in the last year is C$36.50.

Top 10 Warren Buffett Stocks To Invest In Right Now: RXI Pharmaceuticals Corporation(RXII)

Advisors' Opinion:
  • [By Lisa Levin] Gainers MoSys, Inc. (NASDAQ: MOSY) shares rose 44.7 percent to $2.20 in pre-market trading after the company reported better-than-expected Q1 results and issued strong Q2 forecast. The Trade Desk, Inc. (NASDAQ: TTD) rose 23.2 percent to $65.01 in pre-market trading after the company reported upbeat results for its first quarter. The company also issued strong second-quarter and FY18 sales guidance. Immersion Corporation (NASDAQ: IMMR) rose 17 percent to $13.55 in pre-market trading after reporting upbeat Q1 results. Akcea Therapeutics, Inc. (NASDAQ: AKCA) rose 13.8 percent to $23.50 in pre-market trading after the company disclosed that the FDA Advisory Committee voted in favor of WAYLIVRA for the treatment of familial chylomicronemia syndrome. RXi Pharmaceuticals Corporation (NASDAQ: RXII) rose 9.4 percent to $2.45 in pre-market trading after the company disclosed a collaboration with Iovance Biotherapeutics. ViewRay, Inc. (NASDAQ: VRAY) rose 13.7 percent to $8.80 in pre-market trading after reporting upbeat quarterly earnings. ForeScout Technologies, Inc. (NASDAQ: FSCT) rose 5.6 percent to $32.00 in pre-market trading after falling 2.26 percent on Thursday. Net 1 UEPS Technologies, Inc. (NASDAQ: UEPS) shares rose 5.6 percent to $9.30 in pre-market trading after reporting Q3 results. Aflac Incorporated (NYSE: AFL) rose 4.7 percent to $47.50 in pre-market trading. Clean Energy Fuels Corp. (NASDAQ: CLNE) rose 4.2 percent to $2.24 in pre-market trading following Q1 earnings. Kratos Defense & Security Solutions, Inc. (NASDAQ: KTOS) shares rose 3.7 percent to $11.00 in pre-market trading after the company reported Q1 earnings.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By Lisa Levin] Gainers ARMO BioSciences, Inc. (NASDAQ: ARMO) shares rose 67.5 percent to $49.96 in pre-market trading after Eli Lilly and Company (NYSE: LLY) announced plans to acquire ARMO BioSciences for $50 per share. Turtle Beach Corporation (NASDAQ: HEAR) rose 62.8 percent to $11.30 in pre-market trading after the company reported Q1 results and raised its FY18 outlook. vTv Therapeutics Inc. (NASDAQ: VTVT) rose 23.4 percent to $2.11 in pre-market trading following announcement that the company will pre-specify new subgroup with the FDA and report Phase 3 Part B results in June. Resonant Inc. (NASDAQ: RESN) rose 19.1 percent to $5.00 in pre-market trading after reporting Q1 results. RXi Pharmaceuticals Corporation (NASDAQ: RXII) rose 17.7 percent to $2.39 in pre-market trading following Q1 results. Clean Energy Fuels Corp. (NASDAQ: CLNE) rose 15.2 percent to $2.20 in pre-market trading after French company Total announced plans to acquire 25 percent stake in Clean Energy Fuels for $83.4 million. Everspin Technologies, Inc. (NASDAQ: MRAM) rose 14.6 percent to $8.50 in pre-market trading after the company reported strong results for its first quarter. Carvana Co. (NYSE: CVNA) shares rose 11 percent to $27.50 in pre-market trading after reporting upbeat Q1 sales. Sunrun Inc. (NASDAQ: RUN) rose 8.9 percent to $10.70 in pre-market trading following upbeat quarterly earnings. MediciNova, Inc. (NASDAQ: MNOV) rose 8.1 percent to $11.35 in pre-market trading after the company announced opening of Investigational New Drug Application for MN-166 (ibudilast) in glioblastoma. New Gold Inc. (NYSE: NGD) shares rose 7.7 percent to $2.65 in pre-market trading after the company reported that its President and CEO Hannes Portmann left the company. The company named Raymond Threlkeld as successor. Otter Tail Corporation (NASDAQ: OTTR) shares rose 7.4 percent to $46.60 in the pre-market trading session. Himax Technologies, Inc. (NASDAQ: HIMX) shares rose

Top 10 Warren Buffett Stocks To Invest In Right Now: Live Ventures Incorporated(LIVE)

Advisors' Opinion:
  • [By Ethan Ryder]

    Live Ventures (NASDAQ: LIVE) and PennantPark Investment (NASDAQ:PNNT) are both small-cap computer and technology companies, but which is the better business? We will compare the two companies based on the strength of their valuation, dividends, analyst recommendations, risk, earnings, profitability and institutional ownership.

Top 10 Warren Buffett Stocks To Invest In Right Now: Sibanye Gold Limited(SBGL)

Advisors' Opinion:
  • [By Lisa Levin]

     

    Losers Netshoes (Cayman) Limited (NASDAQ: NETS) shares dipped 43.73 percent to close at $2.87 on Tuesday as the company posted downbeat Q1 results. Cesca Therapeutics Inc. (NASDAQ: KOOL) shares dropped 29.01 percent to close at $0.80 after reporting Q1 results. SenesTech, Inc. (NASDAQ: SNES) shares fell 22.2 percent to close at $0.340 after reporting Q1 miss. Vipshop Holdings Limited (NYSE: VIPS) fell 19.95 percent to close at $12.08 after the company reported weaker-than-expected earnings for its first quarter on Monday. Image Sensing Systems, Inc. (NASDAQ: ISNS) fell 19.68 percent to close at $3.775 after reporting earnings were down year over year. First quarter earnings came in flat, down from 4 cents per share in the same quarter of last year. Sales came in at $3.01 million. Boxlight Corporation (NASDAQ: BOXL) dropped 18.47 percent to close at $9.62 on Tuesday after surging 77.44 percent on Monday. ENDRA Life Sciences Inc. (NASDAQ: NDRA) declined 16.21 percent to close at $2.43. ENDRA Life Sciences is expected to release quarterly earnings today. ALJ Regional Holdings, Inc. (NASDAQ: ALJJ) shares fell 16.13 percent to close at $1.79. Switch Inc (NYSE: SWCH) shares dropped 14.93 percent to close at $13.16 following a first-quarter earnings miss. Restoration Robotics Inc (NASDAQ: HAIR) fell 14.42 percent to close at $3.68 after reporting a first-quarter earnings miss. iCAD, Inc. (NASDAQ: ICAD) declined 13.01 percent to close at $3.41 following Q1 results. Intersections Inc. (NASDAQ: INTX) fell 12.44 percent to close at $1.97. Histogenics Corporation (NASDAQ: HSGX) declined 12.24 percent to close at $2.15. AZZ Inc. (NYSE: AZZ) fell 12.1 percent to close at $39.60 following Q3 earnings. Hallador Energy Company (NASDAQ: HNRG) fell 11.1 percent to close at $6.49. Integrated Media Technology Limited (NASDAQ: IMTE) dropped 10.66 percent to close at $16.93 on Tuesday. Myomo, Inc. (NYSE: MYO) slipp
  • [By Joseph Griffin]

    TRADEMARK VIOLATION WARNING: “Sibanye Gold Ltd (SBGL) Receives Average Recommendation of “Buy” from Analysts” was originally reported by Ticker Report and is the property of of Ticker Report. If you are reading this story on another site, it was copied illegally and republished in violation of U.S. & international copyright & trademark laws. The correct version of this story can be viewed at https://www.tickerreport.com/banking-finance/3364474/sibanye-gold-ltd-sbgl-receives-average-recommendation-of-buy-from-analysts.html.

  • [By Logan Wallace]

    Shares of Sibanye Gold Ltd (NYSE:SBGL) have been assigned a consensus rating of “Buy” from the seven brokerages that are currently covering the company, MarketBeat.com reports. Three equities research analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company.

  • [By Paul Ausick]

    Sibanye Gold Ltd. (NYSE: SBGL) traded down about 1.6% Thursday and posted a new 52-week low of $3.75 after closing Wednesday at $3.81. The stock’s 52-week high is $10.60. Volume totaled around 3 million, about 15% below the daily average. The company had no specific news. Another stock that has turned it around today and looks to close about 1% higher.

  • [By Paul Ausick]

    Sibanye Gold Ltd. (NYSE: SBGL) traded down about 8.4% Monday to post a new 52-week low of $3.16 after closing Friday at $3.45. The stock’s 52-week high is $8.66. Volume was about 35% above the daily average of around 3.9 million shares. The company had no specific news.

Top 10 Warren Buffett Stocks To Invest In Right Now: Agenus Inc.(AGEN)

Advisors' Opinion:
  • [By Max Byerly]

    Agenus (NASDAQ:AGEN) shares traded up 5.6% during mid-day trading on Thursday . The stock traded as high as $3.44 and last traded at $3.60. 39,070 shares were traded during mid-day trading, a decline of 97% from the average session volume of 1,431,827 shares. The stock had previously closed at $3.41.

  • [By Cory Renauer]

    Harnessing the power of the immune system to fight cancer is a big deal and Agenus Inc. (NASDAQ:AGEN) looks like a great way to follow the trend. This stock trades like a small-cap biotech, but a couple of candidates coming through its pipeline could help push annual revenue past the $1 billion mark. Plus, by this time next year, the company could have half a dozen or so new candidates in clinical trials.

  • [By Shane Hupp]

    Shares of Agenus (NASDAQ:AGEN) dropped 9.8% during trading on Monday following a dissappointing earnings announcement. The stock traded as low as $3.30 and last traded at $3.32. Approximately 2,421,286 shares changed hands during mid-day trading, an increase of 53% from the average daily volume of 1,586,724 shares. The stock had previously closed at $3.68.

  • [By Cory Renauer]

    Attention bargain shoppers: There could be some deals in aisle biotech.�Agenus Inc.�(NASDAQ:AGEN)�and�Regeneron Pharmaceuticals (NASDAQ:REGN) dished out some disappointing losses in recent months, but the market's reaction to recent events seems a bit overdone.��

Saturday, May 26, 2018

Hot Dividend Stocks To Own Right Now

tags:CRMT,SNN,RUBI,

Patience in investing is a virtue. If you're willing to hold on until the end of 2017 with Symphony International Holdings (OTC:SYNNF), then you could be rewarded with a 9% dividend and a 40% return on capital.

Symphony, a London-listed, closed-end investment fund, currently trades with a 40% discount to its net asset value. Its assets aim to capture the growing economic power of the middle classes in Southeast Asia, including Minor International, a Thai-listed hotels and restaurants group, real estate and healthcare. Its most recent investment is in the show rooms of the Christian Liaigre luxury furniture brand.

There is more to Symphony than just a discount. The assets have grown with the middle classes in Asia and should continue to do so. This has been rewarded with a year of steady increases in the share price and with a dividend that has grown in each of the past three years since it began paying out. This could be a valuable dividend stock.

There is also a significant margin of safety. Cash and listed securities held by Symphony cover the share price by approximately 1.15 times, with the rest of the full net asset value made up by non-listed securities and real estate. A very conservative appraisal of the value of the assets was performed in 2014, and little has changed since then.

Hot Dividend Stocks To Own Right Now: America's Car-Mart Inc.(CRMT)

Advisors' Opinion:
  • [By Lisa Levin] Gainers Forward Pharma A/S (NASDAQ: FWP) shares gained 88.18 percent to close at $4.14 on Tuesday. Regional Health Properties, Inc. (NYSE: RHE) shares jumped 18.04 percent to close at $0.3010 on Tuesday. Precipio, Inc. (NASDAQ: PRPO) shares gained 16.61 percent to close at $0.49 after the nano-cap specialty diagnostics company said it saw an acceleration of sales in its Pathology services in April. The company now expects to see a sequential double digit quarterly sales growth. Arcturus Therapeutics Ltd. (NASDAQ: ARCT) rose 16.09 percent to close at $7.00 on Tuesday. America's Car-Mart, Inc. (NASDAQ: CRMT) gained 14.53 percent to close at $62.65 after reporting upbeat Q4 results. NanoString Technologies, Inc. (NASDAQ: NSTG) shares surged 12.64 percent to close at $13.19. Geron Corporation (NASDAQ: GERN) gained 12.12 percent to close at $4.07 on Tuesday. Quotient Limited (NASDAQ: QTNT) shares climbed 11.58 percent to close at $6.55 on Tuesday. American Equity Investment Life Holding Company (NYSE: AEL) rose 11.23 percent to close at $32.28 following a report from Reuters that the company is looking for a sale. iQIYI, Inc. (NASDAQ: IQ) gained 11.15 percent to close at $22.52. Veracyte, Inc. (NASDAQ: VCYT) rose 10.4 percent to close at $7.11. Stein Mart, Inc. (NASDAQ: SMRT) gained 10.26 percent to close at $3.33. Stein Mart is expected to release quarterly earnings on May 23. MiMedx Group, Inc. (NASDAQ: MDXG) shares rose 10.11 percent to close at $8.06. The Container Store Group, Inc. (NYSE: TCS) gained 8.2 percent to close at $8.18. Container Store reported weaker-than-expected earnings for its fourth quarter after the closing bell. Photronics, Inc. (NASDAQ: PLAB) shares gained 7.69 percent to close at $9.10 after the company reported upbeat Q2 results. Micron Technology, Inc. (NASDAQ: MU) rose 6.4 percent to close at $59.03 after reporting a $10 billion buyback plan.

     

  • [By Dan Caplinger]

    Tuesday was down day on Wall Street, with major benchmarks losing a quarter percent or more. Market participants spent a lot of time watching the geopolitical situation, where a planned meeting between leaders of North Korea and the U.S. ran into possible hurdles. Yet there wasn't a really big response in some of the financial markets, with oil staying close to the $72-per-barrel mark and 10-year Treasury yields remaining above 3%. Some individual companies had good news that sent their shares higher, however. Micron Technology (NASDAQ:MU), Eldorado Gold (NYSE:EGO), and America's Car-Mart (NASDAQ:CRMT) were among the best performers on the day. Here's why they did so well.

  • [By Lisa Levin] Gainers Regional Health Properties, Inc. (NYSE: RHE) shares surged 56 percent to $0.3980. Precipio, Inc. (NASDAQ: PRPO) shares jumped 34 percent to $0.5632 after the nano-cap specialty diagnostics company said it saw an acceleration of sales in its Pathology services in April. The company now expects to see a sequential double digit quarterly sales growth. SenesTech, Inc. (NASDAQ: SNES) rose 16 percent to $1.45 after trading higher at one point Monday by nearly 300 percent. The nano-cap developer of pest control said the California state government approved the company's ContraPest for user in the state. America's Car-Mart, Inc. (NASDAQ: CRMT) gained 13.3 percent to $61.975 after reporting upbeat Q4 results. Check-Cap Ltd. (NASDAQ: CHEK) shares gained 9.8 percent to $4.92 as the company announced the publication of CE Mark multicenter clinical study results on C-Scan® in Gut. Arcimoto, Inc. (NASDAQ: FUV) rose 8.3 percent to $3.41. Ferroglobe PLC (NYSE: GSM) gained 7 percent to $12.13 following stronger-than-expected quarterly earnings. Photronics, Inc. (NASDAQ: PLAB) shares climbed 6.5 percent to $9.00 after the company reported upbeat Q2 results. Micron Technology, Inc. (NASDAQ: MU) rose 6.2 percent to $58.94 after reporting a $10 billion buyback plan. Blink Charging Co. (NASDAQ: BLNK) gained 6.2 percent to $7.53. Blink Charging disclosed that its vehicle charging network exceeds 125,000 members. The Container Store Group, Inc. (NYSE: TCS) gained 5.4 percent to $7.97. Container Store is expected to release quarterly earnings after the closing bell. Cyren Ltd (NASDAQ: CYRN) shares rose 5.4 percent to $2.95 after reporting Q1 results.

    Check out these big penny stock gainers and losers

  • [By Lisa Levin]

    Shares of America's Car-Mart, Inc. (NASDAQ: CRMT) got a boost, shooting up 17 percent to $63.76 after reporting upbeat Q4 results.

    Precipio, Inc. (NASDAQ: PRPO) shares were also up, gaining 18 percent to $0.4944 after the nano-cap specialty diagnostics company said it saw an acceleration of sales in its Pathology services in April. The company now expects to see a sequential double digit quarterly sales growth.

Hot Dividend Stocks To Own Right Now: Smith & Nephew SNATS, Inc.(SNN)

Advisors' Opinion:
  • [By Lisa Levin]

     

    Losers Heat Biologics, Inc. (NASDAQ: HTBX) shares tumbled 48.59 percent to close at $1.275 on Thursday after the company priced its $18,000,000 public offering. InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) fell 38.77 percent to close at $8.26 on Thursday. Check-Cap Ltd. (NASDAQ: CHEK) shares tumbled 27.43 percent to close at $8.81. Achaogen, Inc. (NASDAQ: AKAO) dropped 24.76 percent to close at $11.06 in reaction to a disappointing update from an FDA AdCom panel. The FDA panel voted favorably for the company's Plazcomicin for treatment of adults with complicated urinary tract infections, but also voted against the therapy to be used as a treatment for bloodstream infections. Anika Therapeutics, Inc. (NASDAQ: ANIK) shares declined 24.68 percent to close at $34.80 after the company posted downbeat quarterly results. LSC Communications, Inc. (NASDAQ: LKSD) shares fell 24.22 percent to close at $12.64 following wider-than-expected Q1 loss. Cardinal Health, Inc. (NYSE: CAH) fell 21.42 percent to close at $50.80 following downbeat quarterly profit. Horizon Global Corporation (NYSE: HZN) dropped 20.42 percent to close at $6.00 following downbeat quarterly earnings. Hornbeck Offshore Services, Inc. (NYSE: HOS) slipped 20.11 percent to close at $2.90 following wider-than-expected Q1 loss. Esperion Therapeutics, Inc. (NASDAQ: ESPR) fell 19.28 percent to close at $36.93. Esperion Therapeutics stock lost roughly a third of its value Wednesday after the company reported mixed Phase III results for its leading drug candidate, bempedoic acid. JP Morgan downgraded Esperion Therapeutics from Neutral to Underweight. Laredo Petroleum, Inc. (NYSE: LPI) declined 17.77 percent to close at $8.98 after the company reported weaker-than-expected Q1 earnings. The Habit Restaurants, Inc. (NASDAQ: HABT) dipped 16.1 percent to close at $8.60 after the company reported downbeat quarterly results. Arcadia Biosciences, Inc. (N
  • [By Benzinga News Desk]

    Weight Watchers (NYSE: WTW) is tipping the scales on Wall Street: Link

    ECONOMIC DATA USA Nonfarm Payrolls for Apr 164.0K vs 189.0K Est; Prior 103.0K. Private Payrolls for Apr 168.0K vs 194.0K Est; Prior 102.0K Unemployment Rate for Apr 3.90% vs 4.00% Est; Prior 4.10% New York Fed President William Dudley is set to speak at 12:45 p.m. ET. The Baker Hughes North American rig count report for the latest week is schedule for release at 1:00 p.m. ET. Federal Reserve Bank of San Francisco President John Williams will speak at 3:00 p.m. ET. Randal Quarles, Vice Chairman for Supervision, is set to speak at 5:30 p.m. ET. Dallas Fed President Robert Kaplan will speak at 8:00 p.m. ET. Federal Reserve Bank of Atlanta President Raphael Bostic is set to speak at 8:00 p.m. ET. Kansas City Fed President Esther George will speak at 8:00 p.m. ET. ANALYST RATINGS RBC upgraded Benefitfocus (NASDAQ: BNFT) from Sector Perform to Outperform Stephens upgraded FMC (NYSE: FMC) from Equal-Weight to Overweight RBC downgraded Colfax (NYSE: CFX) from Outperform to Sector Perform Deutsche Bank downgraded Smith & Nephew (NYSE: SNN) from Hold to Sell

    This is a tool used by the Benzinga News Desk each trading day — it's a look at everything happening in the market, in five minutes. To get the full version of this note every morning, click here.

Hot Dividend Stocks To Own Right Now: The Rubicon Project, Inc.(RUBI)

Advisors' Opinion:
  • [By Max Byerly]

    Rubicon Project (NYSE:RUBI) was upgraded by stock analysts at ValuEngine from a “strong sell” rating to a “sell” rating in a research report issued on Wednesday.

  • [By Ethan Ryder]

    Rubicon Project (NYSE: RUBI) is one of 44 publicly-traded companies in the “Computer programming, data processing, & other computer related” industry, but how does it weigh in compared to its competitors? We will compare Rubicon Project to related companies based on the strength of its analyst recommendations, valuation, institutional ownership, dividends, profitability, earnings and risk.

Friday, May 25, 2018

Innovative Industrial Properties: Betting On Medical Cannabis

Innovative Industrial Properties (IIPR) is breaking out higher following continued expansion in the company's operations. As the medical cannabis industry grows in the U.S., IIPR is at the forefront of providing cultivation and processing facilities to such companies. As regulation is rolled back on medical cannabis, its share price has trended higher, currently trading near record levels. I am buying stock in this name as it presents a first mover advantage in the burgeoning industry.

Fundamental Narrative

IIPR is an attractive buy at current levels due to the expanding scope of the legalized medical cannabis industry in the U.S., as well as the company being at the forefront of the REIT industry in this category.

The company is a self-advised Maryland corporation focused on the acquisition, ownership and management of specialized industrial properties leased to experienced, state-licensed operators for their regulated medical-use cannabis facilities.

At the end of the most recent quarter, IIPR owned five properties in four states, totaling approximately 617,000 square feet, which were 100% leased on a long-term basis to high quality licensed, medical-use cannabis operators, according to its earnings call. Its initial blended yield on these properties is 15.8% with each lease providing minimum annual escalations ranging from 3.25% to 4%.

The company is very active in terms of acquisitions as they continuously look for opportunities in this growing industry. In December, they closed on a sale-leaseback transaction for a 358,000 square-foot medical-use cannabis cultivation and processing facility with a farm in Arizona and closed on two other sale-leaseback transactions with Vireo in the state of New York, as well as Minnesota in October and November, according to its earnings call.

The medical-use cannabis industry is constantly evolving, including strong growth of existing state markets and the rollout of new programs passed to numerous states by popular vote or legislation in recent years.

Within the nascent industry, management is witnessing amazing growth with state regulated medical-use cannabis markets now comprising a large majority of the United States. Congress has enacted spending bills since 2014 with a provision that has been interpreted by courts as preventing the Department of Justice from using funds to interfere with the implementation of state medical-use cannabis laws, aiding IIPR's ultimate growth effort.

The provision was again included in the congressional spending bill enacted on March 23rd, which carry through September 30 of 2018, according to management. This signals that the Federal Government is largely stepping out of the way of the industry as many of the medical cannabis studies have shown to address the needs of a number of important ailments.

The company's current markets are in New York, Arizona, Maryland, and Minnesota, where they have five properties located, with continued potential in each. IIPR is seeing a lot of encouraging signs with both growth and regulation rollback in New York.

The company purchased its first New York property in December 2016 with PharmaCann for a 15-year initial term and are all in initial yield of about 17% on a triple net basis, according to its earnings call. PharmaCann is a multistate operator with two cultivation facilities and four medical-use cannabis dispensers in Illinois, as well as IIPR's cultivation facility in four medical-use cannabis dispensaries in New York.

In order to enable broader access to treatment, New York has taken several positive steps including expansion of the pool of potential recommending health professionals to include nurse practitioners and physician assistants, allowing for home delivery of the medicine, the streamlining of the registration process for practitioners and certification process for patients and perhaps most importantly the introduction of chronic pain and PTSD as additional qualifying condition, according to its earnings call.

The market potential and estimated overall size of the illicit market in New York is nearly $3 billion, with an estimated $254 million of sales in New York's legal market by 2021, representing a compounded annual growth rate from 2016 of 48%, signaling the large growth potential for IIPR and its partners.

Its partner in Arizona, Pharma, is one of the largest wholesalers of medical-use cannabis in the Arizona market, with a highly experienced multidisciplinary management team that is well positioned to grow the Pharma's market share in Arizona and facilitate expansion into other states, according to its earnings call. Arizona's medical-use cannabis program is further along and mature than New York, having commenced medical-use cannabis sales in 2010.

According to the Arizona Department of Health Services, there are over 150,000 qualifying patients in the Arizona's medical cannabis program as of February 2018, representing an increase of over 30% year-over-year with over 85% of registered patients utilizing medical cannabis to treat chronic pain, according to its earnings call.

Moreover, in Maryland, although it's still in its very early stages with the first dispensary opened in late 2017, management is optimistic regarding the development of the legal medical-use cannabis market, driven by Maryland's population size and anticipated demand, the inclusion of PTSD in chronic pain among the initial qualifying conditions and the general view from regulators and policymakers that the industry represents an economic development opportunity, according to management.

Within its acquisition pipeline, IIPR is focused on investing the proceeds from its recently completed follow-on common stock offering in high quality assets and top tiered tenants. In the first quarter, management executed agreements to purchase two properties for a total investment of $10.5 million.

In addition, they executed two nonbinding letters of intent for two properties representing a total expected additional investment of approximately $25 million to $30 million with final amounts determined after they complete its review, signaling the growth prospects for the company. Management is actively evaluating its pipeline of approximately $100 million in additional acquisitions spanning numerous states that have approved medical-use cannabis programs.

With regards to California, management is engaged in numerous discussions with high-quality cultivators there. As with any emerging dynamic high growth industry, IIPR is developing its acquisition strategy and criteria accordingly.

Below is a chart of the company's revenue and earnings per share. Over the last few months, IIPR's revenue has risen substantially, while its EPS is in positive territory. With management's continued focus of expansion alongside more states legalizing medical cannabis, the company's operations look primed to continue growing both on the top and bottom line.

Price Action

The company's share price has traded higher since its IPO, with recent strength on its strong earnings announcement. Advancements in the medical cannabis industry, as well as deregulation in many states have aided the company's share price in recent months. The company is actively looking to expand into new properties as opportunities arise.

Its share price is breaking out to record highs, following a recent consolidation over the last few months. Breaking above the $34 level is significant as it had acted as strong resistance in recent months. The continued expansion of this industry should fuel the company's share price higher in coming quarters.

Conclusion

IIPR is breaking out higher following continued expansion in the company's operations. As the medical cannabis industry grows in the U.S., IIPR is at the forefront of providing cultivation and processing facilities to such companies. As regulation is rolled back on medical cannabis, its share price has trended higher, currently trading near record levels. I am buying stock in this name as it presents a first mover advantage in the burgeoning industry.

Disclosure: I am/we are long IIPR.

I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Thursday, May 24, 2018

Eagle Materials Inc (EXP) Files 10-K for the Fiscal Year Ended on March 31, 2018

Eagle Materials Inc (NYSE:EXP) files its latest 10-K with SEC for the fiscal year ended on March 31, 2018. Eagle Materials Inc supplies building products which are used in residential, industrial, commercial, and infrastructure construction. Its segments include Cement, Concrete and Aggregates, Gypsum Wallboard, Recycled Paperboard, and Oil and Gas Proppants. Eagle Materials Inc has a market cap of $5.26 billion; its shares were traded at around $108.93 with a P/E ratio of 20.65 and P/S ratio of 3.85. The dividend yield of Eagle Materials Inc stocks is 0.37%. Eagle Materials Inc had annual average EBITDA growth of 7.00% over the past ten years.

For the last quarter Eagle Materials Inc reported a revenue of $284.7 million, compared with the revenue of $278.7 million during the same period a year ago. For the latest fiscal year the company reported a revenue of $1.4 billion, an increase of 14.5% from last year. For the last five years Eagle Materials Inc had an average revenue growth rate of 14.7% a year.

The reported diluted earnings per share was $5.28 for the year, an increase of 28.8% from previous year. Over the last five years Eagle Materials Inc had an EPS growth rate of 28% a year. The Eagle Materials Inc had a decent operating margin of 21.46%, compared with the operating margin of 23.14% a year before. The 10-year historical median operating margin of Eagle Materials Inc is 14.68%. The profitability rank of the company is 8 (out of 10).

At the end of the fiscal year, Eagle Materials Inc has the cash and cash equivalents of $9.32 million, compared with $6.56 million in the previous year. The long term debt was $620.9 million, compared with $605.3 million in the previous year. Eagle Materials Inc has a financial strength rank of 6 (out of 10).

At the current stock price of $108.93, Eagle Materials Inc is traded at 22.5% premium to its historical median P/S valuation band of $88.92. The P/S ratio of the stock is 3.85, while the historical median P/S ratio is 3.13. The stock gained 10.08% during the past 12 months.

Directors and Officers Recent Trades:

EVP & General Counsel James H Graass sold 10,000 shares of EXP stock on 05/15/2018 at the average price of $110. The price of the stock has decreased by 0.97% since.

For the complete 20-year historical financial data of EXP, click here.

Wednesday, May 23, 2018

Top 5 Safest Stocks To Invest In 2018

tags:ATRS,GAPFF,BRCM,STZ,SFS,

Virtually all companies talk about innovation. Only a few, like Tesla Inc (NASDAQ:TSLA), back up their claims with substantive results. But lately, TSLA hasn’t looked like the cocksure organization for which they’re renowned. With shares dropping more than 5.5% on Thursday, investors openly wonder: should I buy Tesla stock? Or is going short Tesla the safest action?

Throughout my time covering TSLA, I’ve generally maintained a positive outlook. Thus, I’m not one to short Tesla. Sure, the stock has a reputation for being wild, even compared to other technology firms. Plus, CEO Elon Musk doesn’t do things the conventional way. The man launched his Tesla Roadster into space. And not just any roadster but his personal ride.

But the company’s (and the founder’s) quirks are what endeared me to TSLA stock. In the ultra-competitive automobile market, you need whatever distinctions you can get. At least, that was what proved successful in the past. But recently, many investors consider TSLA’s “my way or the highway” attitude a liability. Thus, the cries to short Tesla.

Top 5 Safest Stocks To Invest In 2018: Antares Pharma, Inc.(ATRS)

Advisors' Opinion:
  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Antares Pharma (ATRS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    BidaskClub upgraded shares of Antares Pharma (NASDAQ:ATRS) from a buy rating to a strong-buy rating in a research note issued to investors on Tuesday morning.

  • [By Stephan Byrd]

    Antares Pharma, Inc. (NASDAQ:ATRS) Director Jacques Gonella sold 300,000 shares of the firm’s stock in a transaction dated Wednesday, May 9th. The stock was sold at an average price of $2.47, for a total value of $741,000.00. Following the completion of the sale, the director now directly owns 11,936,413 shares of the company’s stock, valued at approximately $29,482,940.11. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.

Top 5 Safest Stocks To Invest In 2018: Aimia Inc. (GAPFF)

Advisors' Opinion:
  • [By SEEKINGALPHA.COM]

    Aimia (OTCPK:GAPFF) (TSX: AIM, AIM.PR.A, AIM.PR.B, AIM.PR.C)

    As some background, we are intimately familiar with Aeroplan and Air Canada (OTCQX:ACDVF) not just as investors but as extraordinarily heavy consumers. As both an Air Canada top tier elite and Aeroplan top tier member I generate well in excess of 1.5 million Aeroplan miles annually, half from flying Air Canada and its partners and the other half from spending. As consumers we were concerned with Air Canada's decision (though we expect more details to come out that will alleviate these concerns) but as investors we understand that the fundamental business model of mileage programs are incredibly attractive and that Aimia presents an incredibly rare and lucrative investment opportunity for the investor discerning enough to dig into the company.

Top 5 Safest Stocks To Invest In 2018: Broadcom Corporation(BRCM)

Advisors' Opinion:
  • [By Paul Ausick]

    Broadcom Inc. (NASDAQ: BRCM) traded down about 1.4% Friday and posted a new 52-week low of $222.00 after closing Thursday at $225.25. The stock’s 52-week high is $285.68. Volume totaled around 3.9 million, just under the daily average of about 4.1 million. The company had no specific news.

Top 5 Safest Stocks To Invest In 2018: Constellation Brands Inc(STZ)

Advisors' Opinion:
  • [By Steve Symington, Jeremy Bowman, and Demitrios Kalogeropoulos]

    To that end, we asked three top Motley Fool investors to each pick a stock that they believe could double your money. Read on to learn why they like Markel (NYSE:MKL),�Baozun (NASDAQ:BZUN), and Constellation Brands (NYSE:STZ).

  • [By Paul Ausick]

    Alcoholic beverage giant Constellation Brands Inc. (NYSE: STZ) acquired a 9.9% stake in Canada’s Canopy Growth for around $190 million. Canopy Growth is North America’s largest publicly traded cannabis-related firm, with a current market cap of $5.6 billion, and it made our list of 2017’s largest marijuana companies.

  • [By ]

    As for some of the larger alcohol companies veering into cannabis, Borchardt said the same can be true. Plus, she noted that alcohol sales have dropped in the states where cannabis has been legalized, leading alcohol companies including Action Alerts PLUS holding Constellation Brands Inc. (STZ) to very seriously weigh entrance to regulated weed.

  • [By ]

    Constellation Brands (STZ) : "This stock's been coming down and I don't think that's right."

    Zendesk (ZEN) : "Companies love working with them. I like ServiceNow (NOW) but this could be one of our cloud kings too."

  • [By Money Morning Staff Reports]

    For example, Fortune 500 spirits maker Constellation Brands Inc. (NYSE: STZ) announced it's investing $191 million into Canopy Growth Corp. (OTCMKTS: TWMJF), the world's largest publicly traded legal marijuana company. With that $191 million investment, Constellation is getting a 9.9% stake in the Canadian company.

  • [By ]

    Perhaps seeing the names of these companies begins to spark some memories. In short, clothing retailer PVH (NYSE: PVH) and beverage company Constellation Brands (NYSE: STZ) were taking heat over the rhetoric of a possible "Border Tax" -- a tax on goods made overseas and imported and sold in the United States.

Top 5 Safest Stocks To Invest In 2018: Smart(SFS)

Advisors' Opinion:
  • [By Lisa Levin]

     

    Losers Heat Biologics, Inc. (NASDAQ: HTBX) shares tumbled 48.59 percent to close at $1.275 on Thursday after the company priced its $18,000,000 public offering. InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) fell 38.77 percent to close at $8.26 on Thursday. Check-Cap Ltd. (NASDAQ: CHEK) shares tumbled 27.43 percent to close at $8.81. Achaogen, Inc. (NASDAQ: AKAO) dropped 24.76 percent to close at $11.06 in reaction to a disappointing update from an FDA AdCom panel. The FDA panel voted favorably for the company's Plazcomicin for treatment of adults with complicated urinary tract infections, but also voted against the therapy to be used as a treatment for bloodstream infections. Anika Therapeutics, Inc. (NASDAQ: ANIK) shares declined 24.68 percent to close at $34.80 after the company posted downbeat quarterly results. LSC Communications, Inc. (NASDAQ: LKSD) shares fell 24.22 percent to close at $12.64 following wider-than-expected Q1 loss. Cardinal Health, Inc. (NYSE: CAH) fell 21.42 percent to close at $50.80 following downbeat quarterly profit. Horizon Global Corporation (NYSE: HZN) dropped 20.42 percent to close at $6.00 following downbeat quarterly earnings. Hornbeck Offshore Services, Inc. (NYSE: HOS) slipped 20.11 percent to close at $2.90 following wider-than-expected Q1 loss. Esperion Therapeutics, Inc. (NASDAQ: ESPR) fell 19.28 percent to close at $36.93. Esperion Therapeutics stock lost roughly a third of its value Wednesday after the company reported mixed Phase III results for its leading drug candidate, bempedoic acid. JP Morgan downgraded Esperion Therapeutics from Neutral to Underweight. Laredo Petroleum, Inc. (NYSE: LPI) declined 17.77 percent to close at $8.98 after the company reported weaker-than-expected Q1 earnings. The Habit Restaurants, Inc. (NASDAQ: HABT) dipped 16.1 percent to close at $8.60 after the company reported downbeat quarterly results. Arcadia Biosciences, Inc. (N
  • [By Shane Hupp]

    Smart & Final (NYSE: SFS) and Kroger (NYSE:KR) are both consumer staples companies, but which is the better business? We will compare the two companies based on the strength of their dividends, institutional ownership, profitability, earnings, analyst recommendations, valuation and risk.